NEW YORK (GenomeWeb News) – DermTech today announced that it has raised $5.6 million in a private round of financing to support future development and commercialization of its qPCR-based melanoma detection assay.

Jacobs Investment Company led the Series B financing with additional investments coming from other existing and new investors, which were not named.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.